tiprankstipranks
Advertisement
Advertisement
Roth sees ‘major silver lining’ in Cingulate complete response letter
PremiumThe FlyRoth sees ‘major silver lining’ in Cingulate complete response letter
2M ago
Naz Rahman Reiterates Buy on Cingulate, Maintains 12‑Month Price Target at $8 Following FDA Manufacturing-Only Setback
Premium
Ratings
Naz Rahman Reiterates Buy on Cingulate, Maintains 12‑Month Price Target at $8 Following FDA Manufacturing-Only Setback
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
CING Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCING Upcoming Earnings Report: What to Expect?
3M ago
Six new option listings on April 22nd
Premium
The Fly
Six new option listings on April 22nd
3M ago
Cingulate files to sell 4.21M shares of common stock for holders
Premium
The Fly
Cingulate files to sell 4.21M shares of common stock for holders
4M ago
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
PremiumTipRanks NewswirePolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
5M ago
Cingulate announces U.S. patent notice of allowance
Premium
The Fly
Cingulate announces U.S. patent notice of allowance
5M ago
Cingulate reports Q4 net loss $6.3M vs. $6.2M last year
Premium
The Fly
Cingulate reports Q4 net loss $6.3M vs. $6.2M last year
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100